ARTICLE | Clinical News
Pollinex Quattro Ragweed: Phase II/III started
September 5, 2005 7:00 AM UTC
AGY began a double-blind, placebo-controlled, Canadian trial in about 240 subjects exposed to controlled quantities of ragweed pollen in an environmental exposure chamber (EEC). AGY's Pollinex-R ragwe...